Skip to Main Content

Author Details

Stan Krajewski
Cellstan-Immunoquant Inc.
1977
270
91
PMIDPaper TitleJournal TitlePublished Year
36795366A Unique Multiplex ELISA to Profile Growth Factors and Cytokines in Cerebrospinal Fluid.Methods Mol Biol2023
36795366A Unique Multiplex ELISA to Profile Growth Factors and Cytokines in Cerebrospinal Fluid.Methods Mol Biol2023
35454092Plg-R<sub>KT</sub> Expression in Human Breast Cancer Tissues.Biomolecules2022
35454092Plg-R<sub>KT</sub> Expression in Human Breast Cancer Tissues.Biomolecules2022
29495105The plasminogen receptor<sub>,</sub> Plg-R<sub>KT</sub><sub>,</sub> is essential for mammary lobuloalveolar development and lactation.J Thromb Haemost2018
29495105The plasminogen receptor<sub>,</sub> Plg-R<sub>KT</sub><sub>,</sub> is essential for mammary lobuloalveolar development and lactation.J Thromb Haemost2018
27351915A peptide for targeted, systemic delivery of imaging and therapeutic compounds into acute brain injuries.Nat Commun2016
27351915A peptide for targeted, systemic delivery of imaging and therapeutic compounds into acute brain injuries.Nat Commun2016
25431066Image analysis algorithms for immunohistochemical assessment of cell death.Methods Mol Biol2015
25431066Image analysis algorithms for immunohistochemical assessment of cell death.Methods Mol Biol2015
26139277Nonstripping "Rainbow" and Multiple Antigen Detection (MAD) Western Blotting.Methods Mol Biol2015
26139277Nonstripping "Rainbow" and Multiple Antigen Detection (MAD) Western Blotting.Methods Mol Biol2015
24421398Mannose supplements induce embryonic lethality and blindness in phosphomannose isomerase hypomorphic mice.FASEB J2014
24421398Mannose supplements induce embryonic lethality and blindness in phosphomannose isomerase hypomorphic mice.FASEB J2014
24593993Traumatic brain injury enhances neuroinflammation and lesion volume in caveolin deficient mice.J Neuroinflammation2014
24593993Traumatic brain injury enhances neuroinflammation and lesion volume in caveolin deficient mice.J Neuroinflammation2014
23035722Inhibition of melanoma development in the Nras((Q61K)) ::Ink4a(-/-) mouse model by the small molecule BI-69A11.Pigment Cell Melanoma Res2013
23902736Small molecule-induced mitochondrial disruption directs prostate cancer inhibition via UPR signaling.Oncotarget2013
23035722Inhibition of melanoma development in the Nras((Q61K)) ::Ink4a(-/-) mouse model by the small molecule BI-69A11.Pigment Cell Melanoma Res2013
23902736Small molecule-induced mitochondrial disruption directs prostate cancer inhibition via UPR signaling.Oncotarget2013
21075086Endoplasmic reticulum protein BI-1 modulates unfolded protein response signaling and protects against stroke and traumatic brain injury.Brain Res2011
21075086Endoplasmic reticulum protein BI-1 modulates unfolded protein response signaling and protects against stroke and traumatic brain injury.Brain Res2011
22049339Vascular ligand-receptor mapping by direct combinatorial selection in cancer patients.Proc Natl Acad Sci U S A2011
21957448Neuronal deletion of caspase 8 protects against brain injury in mouse models of controlled cortical impact and kainic acid-induced excitotoxicity.PLoS One2011
21795689The novel plasminogen receptor, plasminogen receptor(KT) (Plg-R(KT)), regulates catecholamine release.J Biol Chem2011
21592316Effective inhibition of melanoma by BI-69A11 is mediated by dual targeting of the AKT and NF-κB pathways.Pigment Cell Melanoma Res2011
22049339Vascular ligand-receptor mapping by direct combinatorial selection in cancer patients.Proc Natl Acad Sci U S A2011
21795689The novel plasminogen receptor, plasminogen receptor(KT) (Plg-R(KT)), regulates catecholamine release.J Biol Chem2011
21957448Neuronal deletion of caspase 8 protects against brain injury in mouse models of controlled cortical impact and kainic acid-induced excitotoxicity.PLoS One2011
21592316Effective inhibition of melanoma by BI-69A11 is mediated by dual targeting of the AKT and NF-κB pathways.Pigment Cell Melanoma Res2011
20388784Mammalian target of rapamycin activator RHEB is frequently overexpressed in human carcinomas and is critical and sufficient for skin epithelial carcinogenesis.Cancer Res2010
21203491A role for ATF2 in regulating MITF and melanoma development.PLoS Genet2010
20388784Mammalian target of rapamycin activator RHEB is frequently overexpressed in human carcinomas and is critical and sufficient for skin epithelial carcinogenesis.Cancer Res2010
20609350Siah2-dependent concerted activity of HIF and FoxA2 regulates formation of neuroendocrine phenotype and neuroendocrine prostate tumors.Cancer Cell2010
20421299Mixed lineage kinase-3 stabilizes and functionally cooperates with TRIBBLES-3 to compromise mitochondrial integrity in cytokine-induced death of pancreatic beta cells.J Biol Chem2010
21203491A role for ATF2 in regulating MITF and melanoma development.PLoS Genet2010
20609350Siah2-dependent concerted activity of HIF and FoxA2 regulates formation of neuroendocrine phenotype and neuroendocrine prostate tumors.Cancer Cell2010
20421299Mixed lineage kinase-3 stabilizes and functionally cooperates with TRIBBLES-3 to compromise mitochondrial integrity in cytokine-induced death of pancreatic beta cells.J Biol Chem2010
19289554Image analysis algorithms for immunohistochemical assessment of cell death events and fibrosis in tissue sections.J Histochem Cytochem2009
19175524BI-69A11-mediated inhibition of AKT leads to effective regression of xenograft melanoma.Pigment Cell Melanoma Res2009
19584170Down-regulation of epidermal growth factor receptor by selective expansion of a 5'-end regulatory dinucleotide repeat in colon cancer with microsatellite instability.Clin Cancer Res2009
19289554Image analysis algorithms for immunohistochemical assessment of cell death events and fibrosis in tissue sections.J Histochem Cytochem2009
19378084Multiple antigen detection (MAD) western blotting.Methods Mol Biol2009
19378037"Rainbow" western blotting.Methods Mol Biol2009
19584170Down-regulation of epidermal growth factor receptor by selective expansion of a 5'-end regulatory dinucleotide repeat in colon cancer with microsatellite instability.Clin Cancer Res2009
19378084Multiple antigen detection (MAD) western blotting.Methods Mol Biol2009
19378037"Rainbow" western blotting.Methods Mol Biol2009
19175524BI-69A11-mediated inhibition of AKT leads to effective regression of xenograft melanoma.Pigment Cell Melanoma Res2009
18403587Development of diabesity in mice with neuronal deletion of Shp2 tyrosine phosphatase.Am J Pathol2008
18519667Molecular signature of MT1-MMP: transactivation of the downstream universal gene network in cancer.Cancer Res2008
  • 1 - 50 of 540

Recommended Authors

Mayo Clinic
Career Start Year 2002
Number of shared co-authors 0
College of Science & Industry Convergence, Ewha Womans University
Career Start Year 1997
Number of shared co-authors 0
Universitatsspital Basel
Career Start Year 1996
Number of shared co-authors 2
University Health Network, Princess Margaret Cancer Centre
Career Start Year 1995
Number of shared co-authors 3
Indiana University School of Medicine
Career Start Year 1994
Number of shared co-authors 0
Fukuoka University
Career Start Year 1992
Number of shared co-authors 1
Hematology and Clinical Immunology, Heinrich Heine University Dusseldorf
Career Start Year 1992
Number of shared co-authors 2
Universite de Montreal
Career Start Year 1991
Number of shared co-authors 4
American Association for Cancer Research, Henry Ford Hospital, Ludwig Institute for Cancer Research, National Cancer Institute, Salk Institute for Biological Studies, University of Cambridge, University of Texas MD Anderson Cancer Center, Virginia Commonwealth University
Career Start Year 1990
Number of shared co-authors 8
National Human Genome Research Institute
Career Start Year 1990
Number of shared co-authors 3
Princess Margaret Cancer Centre, Ontario Cancer Institute, University Health Network
Career Start Year 1989
Number of shared co-authors 4
9Virginia Commonwealth University
Career Start Year 1988
Number of shared co-authors 2
The University of Texas MD Anderson Cancer Center
Career Start Year 1988
Number of shared co-authors 6
Helen Wills Neuroscience Institute, University of California berkeley
Career Start Year 1988
Number of shared co-authors 0
University of Texas M.D. Anderson Cancer Center
Career Start Year 1987
Number of shared co-authors 1
Johns Hopkins School of Medicine
Career Start Year 1986
Number of shared co-authors 6
National Institute of Neurological Disorders and Stroke
Career Start Year 1986
Number of shared co-authors 2
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Career Start Year 1986
Number of shared co-authors 0
Institute for Research in Immunology and Cancer (IRIC), University of Montreal
Career Start Year 1986
Number of shared co-authors 1
National Institute of Neurological Disorders and Stroke
Career Start Year 1986
Number of shared co-authors 1
Medical University of South Carolina
Career Start Year 1982
Number of shared co-authors 0
Universite Cote d'Azur, INSERM U5
Career Start Year 1982
Number of shared co-authors 4
Center for Molecular Imaging, University of Pittsburgh School of Medicine
Career Start Year 1981
Number of shared co-authors 3
University of Nebraska Medical Center
Career Start Year 1980
Number of shared co-authors 0
Universite de Paris-Cite
Career Start Year 1979
Number of shared co-authors 0
Child and Family Research Institute, University of British Columbia
Career Start Year 1979
Number of shared co-authors 0
University of Cambridge
Career Start Year 1977
Number of shared co-authors 0
University of California san francisco
Career Start Year 1975
Number of shared co-authors 4
University of Alabama at Birmingham
Career Start Year 1974
Number of shared co-authors 2
Mount Sinai Hospital
Career Start Year 1943
Number of shared co-authors 7

Collaborators

Cancer Center, Sanford Burnham Prebys Medical Discovery Institute
Co-authored papers 10
Korea Advanced Institute of Science and Technology (KAIST)
Co-authored papers 6
University of California Riverside
Co-authored papers 6
University Hospital and University of Zurich
Co-authored papers 5
Mayo Clinic
Co-authored papers 5
Institute of Biomedical Engineering (IBME), University of Oxford
Co-authored papers 5
Co-authored papers 5
Buck Institute for Research on Aging
Co-authored papers 4
Brown University, Rhode Island Providence VA Medical Center
Co-authored papers 4
Heinrich Heine University
Co-authored papers 4
Co-authored papers 4
Rutgers Cancer Institute of New Jersey
Co-authored papers 3
Yale School of Medicine
Co-authored papers 3
Rutgers Cancer Institute of New Jersey
Co-authored papers 3
Burnham Institute for Medical Research
Co-authored papers 3
Oregon Health and Science University
Co-authored papers 3
Moffitt Cancer Center
Co-authored papers 3
The Scripps Research Institute, University of California
Co-authored papers 3
University of Pennsylvania
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
Oncology Research Unit, Inc.
Co-authored papers 2
Karolinska Institute
Co-authored papers 2
Department of PediatricsIcahn School of Medicine at Mount SinaiNew YorkNew YorkUSA.
Co-authored papers 2
Peter MacCallum Cancer Centre
Co-authored papers 2
Cancer Research United Kingdom Manchester Institute, University of Manchester
Co-authored papers 2
Center for Neurotrauma, Morehouse School of Medicine, University of Florida
Co-authored papers 2
Cancer Center, Sanford Burnham Prebys Medical Discovery Institute
Co-authored papers 2
Sanford-Burnham-Prebys Medical Discovery Institute
Co-authored papers 2
Yale School of Medicine
Co-authored papers 2